Literature DB >> 2523411

Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.

A M Gewirtz1, B Calabretta, B Rucinski, S Niewiarowski, W Y Xu.   

Abstract

We report that highly purified human platelet factor 4 (PF4) inhibits human megakaryocytopoiesis in vitro. At greater than or equal to 25 micrograms/ml, PF4 inhibited megakaryocyte colony formation approximately 80% in unstimulated cultures, and approximately 58% in cultures containing recombinant human IL 3 and granulocyte-macrophage colony-stimulating factor. Because PF4 (25 micrograms/ml) had no effect on either myeloid or erythroid colony formation lineage specificity of this effect was suggested. A synthetic COOH-terminal PF4 peptide of 24, but not 13 residues, also inhibited megakaryocyte colony formation, whereas a synthetic 18-residue beta-thromboglobulin (beta-TG) peptide and native beta-TG had no such effect when assayed at similar concentrations. The mechanism of PF4-mediated inhibition was investigated. First, we enumerated total cell number, and examined cell maturation in control colonies (n = 200) and colonies (n = 100) that arose in PF4-containing cultures. Total cells per colony did not differ dramatically in the two groups (6.1 +/- 3.0 vs. 4.2 +/- 1.6, respectively), but the numbers of mature large cells per colony was significantly decreased in the presence of PF4 when compared with controls (1.6 +/- 1.5 vs. 3.9 +/- 2.3; P less than 0.001). Second, by using the human leukemia cell line HEL as a model for primitive megakaryocytic cells, we studied the effect of PF4 on cell doubling time, on the expression of both growth-regulated (H3, p53, c-myc,and c-myb), and non-growth-regulated (beta 2-microglobulin) genes. At high concentrations of native PF4 (50 micrograms/ml), no effect on cell doubling time, or H3 or p53 expression was discerned. In contrast, c-myc and c-myb were both upregulated. These results suggested the PF4 inhibited colony formation by impeding cell maturation, as opposed to cell proliferation, perhaps by inducing expression of c-myc and c-myb. The ability of PF4 to inhibit a normal cell maturation function was then tested. Megakaryocytes were incubated in synthetic PF4, or beta-TG peptides for 18 h and effect on Factor V steady-state mRNA levels was determined in 600 individual cells by in situ hybridization. beta-TG peptide had no effect on FV mRNA levels, whereas a approximately 60% decrease in expression of Factor V mRNA was found in megakaryocytes exposed to greater than or equal 100 ng/ml synthetic COOH-terminal PF4 peptide. Accordingly, PF4 modulates megakaryocyte maturation in vitro, and may function as a negative autocrine regulator of human megakaryocytopoiesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523411      PMCID: PMC303850          DOI: 10.1172/JCI114041

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  68 in total

1.  Isolation, crystallization, and primary amino acid sequence of human platelet factor 4.

Authors:  M Hermodson; G Schmer; K Kurachi
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

2.  Platelet factor 4: an inhibitor of collagenase.

Authors:  J Hiti-Harper; H Wohl; E Harper
Journal:  Science       Date:  1978-03-03       Impact factor: 47.728

Review 3.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  Characterization of a chondroitin 4 -sulfate proteoglycan carrier for heparin neutralizing activity (platelet factor 4 ) released from human blood platelets.

Authors:  A J Barber; R Käser-Glanzmann; M Jakábová; E F Lüscher
Journal:  Biochim Biophys Acta       Date:  1972-12-29

5.  Activation of c-myb expression by phytohemagglutinin stimulation in normal human T lymphocytes.

Authors:  G Torelli; L Selleri; A Donelli; S Ferrari; G Emilia; D Venturelli; L Moretti; U Torelli
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

6.  Human platelet factor 4: Purification and characterization by affinity chromatography. Purification of human platelet factor 4.

Authors:  S P Levine; H Wohl
Journal:  J Biol Chem       Date:  1976-01-25       Impact factor: 5.157

7.  Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.

Authors:  E Dmitrovsky; W M Kuehl; G F Hollis; I R Kirsch; T P Bender; S Segal
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

8.  Cell-mediated suppression of megakaryocytopoiesis in acquired amegakaryocytic thrombocytopenic purpura.

Authors:  A M Gewirtz; M K Sacchetti; R Bien; W E Barry
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

9.  Partial purification of thrombopoietin using lectin chromatography.

Authors:  R Hill; J Levin
Journal:  Exp Hematol       Date:  1986-09       Impact factor: 3.084

10.  Amino acid sequence of human platelet factor 4.

Authors:  T F Deuel; P S Keim; M Farmer; R L Heinrikson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

View more
  18 in total

1.  Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro.

Authors:  D Patinkin; S Seidman; F Eckstein; F Benseler; H Zakut; H Soreq
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 2.  Megakaryocyte biology and related disorders.

Authors:  Liyan Pang; Mitchell J Weiss; Mortimer Poncz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  The role of platelet factor 4 in radiation-induced thrombocytopenia.

Authors:  Michele P Lambert; Liqing Xiao; Yvonne Nguyen; M Anna Kowalska; Mortimer Poncz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-08-01       Impact factor: 7.038

4.  CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages.

Authors:  Christian A Gleissner; Iftach Shaked; Kristina M Little; Klaus Ley
Journal:  J Immunol       Date:  2010-03-24       Impact factor: 5.422

Review 5.  In vitro megakaryocyte production and platelet biogenesis: state of the art.

Authors:  Jo-Anna Reems; Nicolas Pineault; Sijie Sun
Journal:  Transfus Med Rev       Date:  2010-01

6.  Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes.

Authors:  Michele P Lambert; Yuhuan Wang; Khalil H Bdeir; Yvonne Nguyen; M Anna Kowalska; Mortimer Poncz
Journal:  Blood       Date:  2009-07-15       Impact factor: 22.113

7.  Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications.

Authors:  Michele P Lambert; Lubica Rauova; Matthew Bailey; Martha C Sola-Visner; M Anna Kowalska; Mortimer Poncz
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

8.  Effect of thrombin on maturing human megakaryocytes.

Authors:  E M Cramer; J M Massé; J P Caen; I Garcia; J Breton-Gorius; N Debili; W Vainchenker
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

9.  Comparative studies of the interaction of human and bovine platelet factor 4 with heparin using histidine NMR resonances as spectroscopic probes.

Authors:  C J Talpas; L Lee
Journal:  J Protein Chem       Date:  1993-06

10.  Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding.

Authors:  K H Mayo; E Ilyina; V Roongta; M Dundas; J Joseph; C K Lai; T Maione; T J Daly
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.